Skip to main content
Standard

Implementation of medical devices future regime

Information on the new regulations for the post-market surveillance of medical devices which come into effect on 16 June 2025.

Documents

Roadmap towards the future regulatory framework for medical devices

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

ANNEX A- Detailed response to WTO comments for The Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Draft Regulations 2023

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Infographic: Timelines for placement of CE marked medical devices on the Great Britain market under the Medical Devices (Amendment) (Great Britain) Regulations 2023

Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Overview

This information is to support you to understand and prepare for the main regulatory updates and upcoming amendments to the Medical Device Regulations 2002.

How the regulations were developed

On 26 June 2022, the MHRA published the government response to the public consultation on the future regulation of medical devices in the United Kingdom. The response outlined the intended regulatory reform including the transitional arrangements for CE marked devices placed on the Great Britain market which were put in place in 2023.

On 9 January 2024, the MHRA released a roadmap towards the future regulatory framework for medical devices. This provided an update on the intended timelines to implement the future core regulations.

On 21 May 2024, following on from stakeholder discussions throughout the first quarter of 2024, the MHRA released a statement of policy intent for recognition by the UK of approvals of medical devices from international regulators. This statement sets out the MHRA proposed policy approach. The final legal text would come into force at the same time as the future core regulations.

On 21 October 2024 the draft Post-Market Surveillance Statutory Instrument was laid in Parliament.  The new regulations  introduce clearer and more robust requirements for post-market surveillance (PMS) that improve patient safety. The Post-market Surveillance Statutory Instrument was signed into law on 16 December 2024.

On 14 November 2024, the MHRA published the Consultation on medical devices regulations: routes to market and in vitro diagnostic devices. The results of this consultation will inform legislative updates to the regulatory framework.

On 11 December 2024, the MHRA published a revised Roadmap towards the future regulatory framework for medical devices. This provides a further update on the intended timelines to implement the future medical device regulations.

On 15 December 2025, the MHRA published an In Vitro Diagnostic (IVD) Medical Device Road Map. This roadmap outlines the planned priority deliverables for the IVD medical device work programme until mid-2027.

Contact

For further information, contact our Customer Services Centre at info@mhra.gov.uk or call 020 3080 6000. Alternatively, contact your trade association:

Sign up for emails or print this page